Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Biotech components
Biotech components
Enzyme
Products 21 to 29 of 29
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Luminase PB-100
by
BASF
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
Germany
+
USA
+
Brazil
+
China
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
85,090,000 EUR
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BASF SE
(ETR)
Value chain stage:
Input
Mascoma Cellulosic Ethanol (Yeast)
by
Lallemand
+
Mascoma
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
179,800,000 USD
Funding types:
Venture Capital
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Optisochem
by
Bio Based Industry- Joint Undertaking (BBI-JU)
Biotech components:
Enzyme
+
Yeast
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:10 (6 years ago)
Date last modified:
2019/09/12 15:10 (6 years ago)
Known funding amount:
16,376,817 EUR
Funding types:
Government
+
Private Funding
Industry:
Energy
+
Industrial
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Chemical
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Platform
Protera Guard (Anti-Mold Food Preservative)
by
Protera
Biotech components:
Enzyme
Business models:
B2B
+
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:35 (5 years ago)
Date last modified:
2020/12/18 14:35 (5 years ago)
Known funding amount:
5,000,000 EUR
Funding types:
Venture Capital
Industry:
Energy
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Food
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Pyrolase Cellulase
by
BASF
+
Verenium
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
USA
+
Canada
+
Mexico
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2019/02/13 15:37 (6 years ago)
Known funding amount:
2,147,483,647 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Open Release
Source:
SynBio Database
Trading symbol:
BASF SE
(XETRA)
Value chain stage:
Finished Product
rHuPH20
by
Halozyme
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/01 09:37 (7 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Health
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
HALO
(NASDAQ)
Value chain stage:
Input
Sitagliptin
by
Codexis
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
37,000,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
CDXS
(NASDAQ)
Value chain stage:
Input
Stevia
by
Evolva
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Additive
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Finished Product
Xylathin Xylanase (#1)
by
BASF
+
Verenium
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2019/05/15 15:44 (6 years ago)
Known funding amount:
2,147,483,647 EUR
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BAS
(ETR)
Value chain stage:
Input
1
2
3
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
